Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Payables: 2020-2022

Historic Payables for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2022 value amounting to $2.7 million.

  • Cullinan Therapeutics' Payables changed negligibly% to $2.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.6 million, marking a year-over-year decrease of 35.99%. This contributed to the annual value of $2.7 million for FY2022, which is 16.06% down from last year.
  • As of FY2022, Cullinan Therapeutics' Payables stood at $2.7 million, which was down 16.06% from $3.2 million recorded in FY2021.
  • In the past 5 years, Cullinan Therapeutics' Payables ranged from a high of $9.7 million in FY2020 and a low of $2.7 million during FY2022.
  • Moreover, its 3-year median value for Payables was $3.2 million (2021), whereas its average is $5.2 million.
  • Data for Cullinan Therapeutics' Payables shows a maximum YoY slumped of 67.26% (in 2021) over the last 5 years.
  • Yearly analysis of 3 years shows Cullinan Therapeutics' Payables stood at $9.7 million in 2020, then plummeted by 67.26% to $3.2 million in 2021, then fell by 16.06% to $2.7 million in 2022.